Abstract-Phospholipase A 2 s (PLA 2 s) constitute a family of enzymes that hydrolyze fatty acids of membrane phospholipids, thus initiating the synthesis of proinflammatory mediators. Various PLA 2 s have been detected in human atherosclerotic arteries (advanced lesions); however, only the secretory group of PLA 2 has been shown to specifically hydrolyze low density lipoprotein (LDL)-associated phospholipids and, as such, may play a potential role in atherogenesis. In the present study, we investigated the expression pattern of group IIa, IV, and V PLA 2 s in human macrophages, which are the key cells involved in the onset and perpetuation of atherosclerosis. Immunohistochemical staining by double labeling showed that the secretory nonpancreatic PLA 2 (snpPLA 2 ) is detectable in macrophages in the intima of early atherosclerotic lesions. Reverse transcription-polymerase chain reaction analysis of RNA extracted from human monocytes clearly showed that expression of group IV PLA 2 was enhanced during differentiation into macrophages, with an onset of induction at days 2 to 3 of differentiation. Group V snpPLA 2 was constitutively expressed on differentiation, whereas the detection of group IIa snpPLA 2 was dependent on both differentiation and subsequent stimulation of macrophages. Indeed, the transcription of group IIa snpPLA 2 in macrophages was induced by treatment with minimally modified or mildly oxidized LDL, whereas native, extensively oxidized, or acetylated LDL had no effect. To our knowledge, this is the first report describing induction of group IIa snpPLA 2 expression in human monocyte-derived macrophages. The mRNA levels of cytosolic PLA 2 group IV and snpPLA 2 group V remained unchanged on LDL treatment. Thus, our results show that the expression of distinct PLA 2 enzymes is regulated not only during differentiation of monocytes into macrophages but also on exposure of macrophages to distinct LDL species. Consequently, our results indicate a potential role for both cytosolic and secretory PLA 2 enzymes in inflammation and in macrophage functions related to atherosclerosis, with a specific role for group IIa snpPLA2 in LDL scavenging. 
A therosclerosis is a chronic inflammatory disease characterized by the early and persistent presence of macrophages. The recruitment of circulating monocytes into the vascular intima and their subsequent transformation into macrophages/ foam cells are key elements of the initiation and development of atherosclerosis. Foam cell formation is a result of macrophage scavenging of modified lipoproteins that have undergone oxidative or enzymatic modification in the vascular wall. 1 However, the mechanisms by which macrophages are transformed into foam cells are not fully elucidated.
Phospholipase A 2 enzymes (PLA 2 s; EC 3.1.1.4) hydrolyze fatty acids esterified at the sn-2 position of glycerophospholipids, thus generating unsaturated, free fatty acids and lysophospholipids. PLA 2 s catalyze the rate-limiting step in the formation of biologically active lipids, including prostaglandins, hydroxy fatty acids, leukotrienes, thromboxanes, and platelet-activating factor. The PLA 2 enzymes comprise a heterogeneous family of enzymes with distinct enzymatic properties, including substrate specificity and Ca 2ϩ requirement. 2 Ten different PLA 2 s have been described, 2,3 and 8 have been found in human tissues, whereas only 3 of them are specifically involved in arachidonic acid release.
The PLA 2 enzymes relevant to arachidonic acid release in human tissues may be grouped as secretory or cytosolic (c) enzymes. The cytosolic group encompasses the group IV 85-kDa PLA 2 s, 4 -6 which are ubiquitously expressed and regulated by micromolar concentrations of Ca 2ϩ and reversible phosphorylation. 7 Several distinct secretory PLA 2 s have been identified 2 ; they require millimolar concentrations of calcium for catalytic activity but do not display any specificity for arachidonic acid in the phospholipid sn-2position. The expression of group IIa 8 and group V 9 secretory nonpancreatic PLA 2 s (snpPLA 2 s) and equally of group IV cPLA 2 has been shown to be regulated in vitro by proinflammatory cytokines such as tumor necrosis factor and interleukin-1. 10, 11 Group IIa and V secretory PLA 2 s have also been reported to be involved in arachidonic acid release during inflammatory conditions. [12] [13] [14] An increased level of secretory PLA 2 in the circulation and locally in the tissue has been found in association with various pathological states, such as rheumatoid arthritis, sepsis, infections, lung inflammation, and psoriasis. [15] [16] [17] [18] PLA 2 enzymes have been detected in atherosclerotic arteries and have been suggested to be involved in the progression of atherosclerosis. 19 -23 By immunofluorescence studies, the group I 22 and IIa 21, 22 snpPLA 2 s and the group IV cPLA 2 22 were found in advanced lesions of human atherosclerotic arteries. Other properties of secretory PLA2s relevant to the development of atherosclerosis relate to their ability to hydrolyze phospholipids in LDL. 21, 24 Also, it has been found that both snpPLA 2 and LDL bind to proteoglycans, 20 thus increasing the availability of LDL as a substrate for snpPLA 2 . Indeed, Aviram and Maor 25 reported that PLA 2 -modified LDL was taken up more avidly by macrophages, leading to enhanced formation of foam cells. Additionally, the snpPLA 2 may contribute to the inflammatory response by releasing proinflammatory lipid mediators, including lysophosphatidylcholine, lyso-platelet-activating factor, and free fatty acids.
Despite the immunohistochemical detection of PLA 2 enzymes in advanced lesions of atherosclerotic arteries, the cellular source of PLA 2 detected either extracellularly or intracellularly in the atherosclerotic intima is uncertain. In our previous study, 21 we detected, by immunohistochemical methods, the snpPLA 2 enzyme in smooth muscle cells in both the media and intima and in foam cells in the intima of advanced atherosclerotic lesions. However, it is still uncertain whether the snpPLA 2 detected in foam cells is expressed by them or rather merely associates with LDL that has infiltrated into the intima and becomes endocytosed as a complex with LDL.
In an effort toward understanding the role of various PLA 2 enzymes in macrophage function during atherosclerosis, we have undertaken to determine the expression pattern of the proinflammatory (groups IIa, IV, and V) PLA 2 enzymes in human monocytes and monocyte-derived macrophages. Subsequently, we investigated the impact of either native, minimally modified, or oxidatively modified LDL on the expression of these enzymes. We report herein for the first time that the expression of group IIa PLA 2 s in human macrophages is upregulated by a brief treatment with either minimally modified (MM) or mildly oxidized (ox) LDL but not with native, extensively oxidized, or acetylated LDL. In contrast, the mRNA levels of groups IV and V PLA 2 remained unchanged, independent of the oxidation status of LDL.
Methods

Materials
Plasma and buffy coats for monocyte isolation were obtained from the Hospital Transfusion Center (Hopital Broussais, Paris, France). RPMI-1640 culture medium and PBS were supplied by BioWhittaker. Pools of human sera (100 to 150 donors) for use in cell culture media were supplied by ATGC Biotechnologies. Nutridoma HU medium was supplied by Boehringer Mannheim. "RNA plus" was from Bioprobe System. Dynazyme DNA polymerase was obtained from Dynazyme (Finnzymes Oy). Moloney murine leukemia virus reverse transcriptase was from Gibco-BRL, and RNasin was from Promega. A mouse monoclonal antibody (mAb), BF1 (subclass IgG2b), kindly provided by Jeff Browning, Biogen Inc, Cambridge, Mass, generated against human recombinant group IIa PLA 2 was used to detect group IIa PLA 2 
Tissue Specimens
Arteries were obtained at autopsy or surgery. All pathological samples were obtained according to institutional guidelines, were quickly frozen in LN 2 , and were stored at Ϫ80°C until sectioning. Tissue samples were imbedded in optimum cutting temperature compound (OCT, TissueTek, Miles Laboratories) and snap-frozen in LN 2 . Freshly cut frozen sections of 5-m thickness were collected on poly-L-lysine-coated slides and allowed to dry for 1 hour before storage at Ϫ20°C. Immediately before being stained, the sections were fixed in ice-cold acetone for 5 minutes.
Immunohistochemistry
Tissue sections were stained with mAbs by using an indirect biotin/ streptavidin/FITC technique described previously. 18, 21 In direct double FITC/TRITC detection, the following antibodies were used: mouse mAb BF1 (subtype IgG2b), recognizing group IIa PLA 2 , and an mAb specific for macrophage marker CD68 (subtype IgG1) were used in double-labeling experiments detected with FITC-or TRITC-conjugated subtype-specific rabbit polyclonal antibodies diluted 1:25 or 1:20, respectively, in PBS with 1.2% BSA. Staining with secondary antibodies alone or with an irrelevant primary mAb TWAR was used as a control for nonspecific fluorescence. The microscope was equipped with a double-channel filter set with an excitation range of 450 to 490 nm and of 510 to 560 nm; barrier filters sensitive at 520 and 590 nm were included, thus allowing separation of the green (FITC) and red (TRITC) images.
Characterization of Human Monocyte-Derived Macrophages
Monocytes and macrophages were characterized with specific antibodies, which were detected by indirect immunostaining. CD14 and CD68 were used as specific makers for monocytes and CD3, for lymphocytes. At day 14 of culture, all adherent cells were CD68-positive and CD3-negative, thus indicating the absence of T cells.
Isolation, Culture, and Treatment of Human Monocyte-Derived Macrophages
Human mononuclear cells were isolated from buffy coats of cells in blood samples drawn from individual healthy donors (20 to 35 mL) as described earlier. 26 In brief, buffy coats diluted with PBS (1:1, vol/vol) were carefully loaded onto a Ficoll gradient under sterile conditions. After an initial centrifugation step (20 minutes, 2700g), monocytes were collected at the interface and then washed 3 times at room temperature in PBS containing 0.1% EDTA (successively at 1000g, 340g, and 160g for 10 minutes) and then once in PBS alone at 160g for 10 minutes. Finally, the cell pellet was resuspended in RPMI-1640 medium containing gentamicin (40 g/mL) and glutamine (0.05%). A typical monocyte preparation yielded 100ϫ10 6 cells per donor. The cells were seeded at a density of 3ϫ10 6 cells per well in Primaria 6-well dishes. After 45 minutes of adherence, the cells were washed twice with PBS, and finally fresh medium containing 10% pooled human sera was added. The culture medium was changed after 6 days. At day 14 of culture, monocyte-derived macrophages (denoted as macrophages) were washed 2 times with PBS and then incubated for defined time intervals with 100 g/mL native LDL or oxLDL in the aforementioned culture medium, to which 1% (vol/vol) Nutridoma had been added instead of human serum. Incubations were carried out in a humidified 37°C incubator (95% air atmosphere/5% CO 2 ). Cell viability was measured by trypan blue exclusion and by the release of lactic dehydrogenase activity (5% to 10%) into the medium. At the end of the incubation period (6 hours), cells were washed 2 times with PBS, and the total RNA from 6-well plates was immediately extracted with RNA plus.
Lipoprotein Purification and Chemical Modifications
Normolipidemic plasma of healthy blood donors was used to isolate LDL by sequential ultracentrifugation. Native LDLs (dϭ1.024 to 1.050 g/mL) were centrifuged at their upper limiting density, thereafter extensively dialyzed at 4°C against 0.01 mol/L PBS (pH 7.4) deionized with Chelex-100, subjected to a short (1-hour) dialysis in RPMI-1640, and used immediately in cell cultures. Aliquots of LDL were taken to check the purity of each preparation as described elsewhere. 27 Protein content was determined with the use of the bicinchoninic acid assay kit. Copper-oxidized LDLs (oxLDLs) were prepared after dialysis in PBS without EDTA by incubating 500 g of LDL protein per milliliter in PBS containing 2.5 mol/L CuCl 2 for 2, 6, or 48 hours at 37°C under sterile conditions. At the end of the incubation period, oxidations were stopped with EDTA (1 mmol/L), and LDLs were extensively dialyzed at 4°C, first against PBS (pH 7.4) and then against RPMI-1640, and subsequently filtered through a 0.22-m filter (Millipore). The time course of the copper-induced oxidation of LDL was deduced from the spectrophotometric measurement of conjugated-diene formation at 234 nm. The electrophoretic mobility was expressed as that of oxLDL relative to that of native LDL (ie, relative electrophoretic mobility [REM]). 28 Determination of the content of thiobarbituric acid-reacting substances, expressed as malondialdehyde equivalents 29 in oxLDL, provided an estimation of the degree of lipid oxidation. Typically, native LDL preparations contained Ͻ1.3 nmol/mg LDL protein (nϭ2). For other forms of altered LDL, respective values were as follows: MM-LDL, 5.3Ϯ4; 2-hour-oxidized LDL (designated as mildly oxidized LDL), 11.5Ϯ5; 6-hour-oxidized LDL (designated as moderately oxidized LDL), 23.4Ϯ12; and 48-hour-oxidized LDL (designated as extensively oxidized LDL), 61Ϯ2. Acetylated LDLs were prepared according to the procedure of Basu et al 30 and typically had REM values of 3 to 4. Endotoxin content of all LDL preparations was measured with the chromogenic Limulus amebocyte lysate kit and was always Ͻ50 pg/100 g LDL protein.
RNA Isolation
Total RNA was isolated from adherent macrophages in 6-well culture dishes with RNA plus according to the protocol of the manufacturer. RNA concentrations were spectrophotometrically determined at 260 nm.
Reverse Transcription (RT) and Polymerase Chain Reaction (PCR)
First-strand cDNA synthesis was generated from 2 g of total RNA by using random hexamers as primers. The RT reaction was performed in a final volume of 20 L and contained 5 ng/mL random hexamers, 1 mmol/L dNTP, 2 U/L RNasin (Promega), and 10 U/L of Moloney murine leukemia virus reverse transcriptase (Gibco-BRL). The reaction was carried out at 37°C for 60 minutes. Human PLA 2 enzymes and ␤-actin were amplified from 4 to 6 L of the cDNA reaction by using specific gene primers. PCRs were performed in a final volume of 50 L containing 0.4 mmol/L of each primer and 1.2 U of Dynazyme DNA polymerase. Primers synthesized according to known human cDNA sequences were the following: 5Ј-GAAGTTGAGACCACCCAGCA-3Ј(forward primer) and 5Ј-GTTGCATCCTTGGGGGATCCTCTG-3Ј (reverse primer) for group IIa snpPLA 2 ; 5Ј-GAGTTTTGGGCGTTTCTGGT-3Ј (forward primer) and 5Ј-ACGGCAGGTTAAATGTGAGC-3Ј (reverse primer) for group IV cPLA 2 ; 5Ј-GCAACATTCGCACACAGTCC-3Ј (forward primer) and 5Ј-CCCTACCAAGTCCTATGACC-3Ј (reverse primer) for group V snpPLA 2 ; and 5Ј-GAAATCGTGCGTGACATTAAG-3Ј (forward primer) and 5Ј-CTAGAAGCATTTGCGGTGGACGAT-GGAGGGGCC-3Ј (reverse primer) for ␤-actin. The PCR consisted of 50 cycles of 50 seconds at 94°C, 50 seconds at 57°C, and 30 seconds at 72°C (for amplification of PLA 2 genes) and 20 cycles of 50 seconds at 94°C, 50 seconds at 65°C, and 30 seconds at 72°C (for amplification of ␤-actin). The PCRs were preceded by 3 minutes at 94°C.
Results
Cellular Localization of snpPLA 2 in Early Intimal Atherosclerotic Lesions
We have recently shown that snpPLA 2 is associated with foamlike cells in the lipid core of advanced lesions in atherosclerotic arteries. 21 In this study, we stained serial sections of early intimal lesions of human aorta, macroscopically characterized by fatty streak formation, with antibodies directed toward group IIa snpPLA 2 and toward the specific macrophage antigen CD68. Morphology and positive anti-CD68 staining easily permitted identification of macrophages ( Figure 1A) . Cells of similar morphology stained positively with antibody specific for snpPLA 2 in the neighboring section ( Figure 1B) . Double labeling was performed by subtypespecific TRITC-conjugated antibody recognizing anti-CD68 ( Figure 1C ) and FITC-conjugated subtype-specific antibody recognizing anti-snpPLA 2 ( Figure 1D ), which showed coexpression of CD68 and snpPLA 2 proteins in the same cell. Thus, the macrophages present in the intimal region in early lesions of atherosclerotic arteries clearly express snpPLA 2 .
Expression of PLA 2 s During Differentiation of Human Monocytes Into Macrophages
For the purpose of this study, we developed an in vitro system that enabled us to examine the expression of distinct isoforms of PLA 2 in human monocytes and in mature macrophages. Therefore, we utilized the calibrated RT-PCR procedure to assess the mRNA levels of different PLA 2 isoforms in human monocytes on differentiation into macrophages. Monocytes were cultured for 0 to 14 days in the presence of human serum, and the RT-PCR analyses were performed on total cellular RNA. PCR amplification of group IIa, IV, and V PLA 2 s was performed by using ␤-actin as a control. The amplifications were performed from the same cDNA preparations to allow relative comparisons between the intensity of different PLA 2 transcripts. Figure 2 shows the time course of expression of PLA 2 isoforms in monocytes and macrophages as evaluated by RT-PCR. Interestingly, the mRNA level of group IV cPLA 2 was increased during differentiation of monocytes into macrophages, the onset occurring at days 2 to 3 of culture. Group IIa snpPLA 2 was detected in neither monocytes nor fully differentiated unstimulated macrophages. Group V snpPLA 2 was expressed at a constant but low level. The RT-PCR mRNA determinations were repeated 3 times with each RNA preparation obtained from 3 independent donors.
Expression of PLA 2 Isoforms in Macrophages Treated With LDL
Native and modified LDLs have been shown to influence expression of genes relevant to atherosclerosis, eg, macrophage scavenger receptors, monocyte chemotactic protein-1, and macrophage colony stimulating factor. 31 To investigate whether the exposure of macrophages to LDL regulated the expression of PLA 2 isoforms in human macrophages, we performed the RT-PCR analysis of total RNA extracted from macrophages differentiated for 14 days and subsequently treated for 6 hours with LDLs oxidized to various extents with copper ions (Figure 3) . Surprisingly, the expression of Monocytes isolated from blood samples of healthy donors (3ϫ10 6 ) were seeded in 6-well dishes and induced to differentiate in the presence of human serum (10%). At the indicated time periods, total cellular RNA was isolated from each well with RNA plus, transcribed, and amplified by using primers specific for the given isoforms of PLA 2 or ␤-actin as described in Methods. After separation, DNA transcripts were detected by ethidium bromide staining (upper panels). cDNA levels were further quantified after background subtraction by using the NIH program Image, version 1.61. After normalization against ␤-actin, PLA 2 cDNA synthesis was expressed as a percentage of square pixels at day 0 of differentiation (lower panel). Representative results from 3 independent experiments are shown. Total RNA from human placental tissue was used as a positive control (lane PC). Lane NC shows the negative control of RT-PCR for amplification in the absence of cellular RNA. The mechanism by which such mildly oxidized LDL affects snpPLA 2 transcription may involve the lipid and/or the protein moieties of LDL. To address this question, we compared the effects of native or oxLDL with those of acetylated LDL on snpPLA 2 mRNA induction in human macrophages. While mildly oxidized LDL produced the expected induction of group IIa snpPLA 2 expression, their acetylated counterparts had no effect on snpPLA 2 mRNA synthesis ( Figure 5 ). Thus, we suggest that the induction of snpPLA 2 transcription is not mediated by the scavenger receptor A family of LDL scavenger receptors. Moreover, we suggest that the stimulatory effect of mildly oxidized LDL on snpPLA 2 expression is not a consequence of massive cholesterol loading of macrophages.
Discussion
Several enzymes of the PLA 2 family have been detected in human atherosclerotic lesions; therefore, raising the question of their participation in atherogenesis is relevant. Monocytederived macrophages play a key role in the initiation of atherosclerosis owing to their ability to create inflammatory reactions and their evolution toward foam cells. However, the presence and regulation of distinct PLA 2 isoforms in human macrophages have received little attention. Previous studies performed on plaques from advanced atherosclerotic lesions have shown that the snpPLA 2 -positive staining was associated with foam cells derived from macrophages. 19, 21 However, such colocalization with macrophages could be a result of endocytosis of snpPLA 2 trapped by modified LDL. In the intima of arterial tissue, both snpPLA 2 and LDL have been found to associate with the same negatively charged glycosaminoglycans. Additionally, the PLA 2 enzymatic activity toward LDL is clearly stimulated by such associations. 20 One may therefore speculate that there is an association between snpPLA 2 and LDL before their eventual endocytosis by macrophages. We therefore undertook this study to examine (1) whether macrophages could be the source of snpPLA 2 , (2) which other PLA 2 isoforms are expressed in macrophages, and (3) how they are regulated on maturation and exposure to LDL. By using specific anti-snpPLA 2 antibodies and antibod- Human monocyte-derived macrophages in RPMI-1640/Nutridoma (1%, vol/vol) were treated for 6 hours with 100 g/mL native LDL (Nat); ox 2h LDL; ox 6h LDL; or acetylated LDL (AcLDL). Total RNA was extracted, transcribed, and subjected to PCR with specific oligonucleotides for group IIa snpPLA 2 s and for ␤-actin. Lane NC shows the negative control of RT-PCR for amplification in the absence of cellular RNA. After separation, DNA transcripts were detected by ethidium bromide staining (upper panel). cDNA levels were further quantified after background subtraction by using the NIH program Image, version 1.61. After normalization against ␤-actin, synthesis of cDNA specific to snpPLA 2 was expressed as a percentage of square pixels of cells treated with native LDL (lower panel). Representative results of 4 independent experiments are shown.
ies toward macrophage antigen CD68, we found that macrophages from the intima of early atherosclerotic lesions contained substantial amounts of immunoreactive snpPLA 2 , as previously demonstrated for advanced lesions. 21 Our results clearly show that snpPLA 2 is already present in macrophages at an early stage of atherosclerosis. Thus, snpPLA 2 may be involved in the initiation of atherogenesis and may function to accelerate the inflammatory reactions and enhance foam cell formation.
Owing to the existence of several homologous variants of secretory PLA 2 , we utilized calibrated RT-PCR analysis to establish precisely the expression pattern of PLA 2 s in human monocyte-derived macrophages. Expressional analysis by RT-PCR is of primary importance because of the possibility of cross-reactivity of antibodies between different groups of secretory PLA 2 . Therefore, we investigated the mRNA expression of group IV cPLA 2 by RT-PCR in human monocytes during differentiation into macrophages and showed that it was strongly elevated, indicating that cPLA 2 may possess important functions in mature macrophage. Indeed, cPLA 2 has also been detected in macrophages in atherosclerotic arteries. 22 Additionally, previous results obtained from macrophage-like cell lines argue in favor of a prominent role of cPLA 2 in macrophage intracellular arachidonic acid signaling and propagation of inflammatory reactions, [32] [33] [34] as well as in functional coupling to the secretory PLA 2 s leading to enzyme activation. 13, 35, 36 Nakamura et al 37 have shown that treatment of human monocytes with macrophage colony stimulating factor stimulated expression of cPLA 2 and promoted its own phosphorylation; thus these authors attributed a role for cPLA 2 in monocyte proliferation and differentiation. Therefore, our results showing an upregulation of cPLA 2 mRNA expression on differentiation corroborate the aforementioned results. 37 In our study, the expression of group V snpPLA 2 remained unchanged during differentiation, whereas group IIa snpPLA 2 could not be detected at any stage of differentiation of human monocytes into macrophages. However, in 1 set of experiments, we were able to show that snpPLA 2 is expressed to some extent in untreated macrophages ( Figure  4) , possibly due to a brief proinflammatory exposure of the monocyte donors before blood donation. Nevertheless, our observations that mildly oxidized LDL increases expression of group IIa PLA 2 , independent of initial snpPLA 2 expression levels, remain valid.
Native and moderately modified LDLs have been shown to exhibit both stimulatory and inhibitory effects on gene transcription, eg, on macrophage scavenger receptors, 38 platelet-activating factor receptor, 26 granulocyte macrophage colony stimulating factor, 39 monocyte chemotactic protein-1, 40, 41 and cellular adhesion molecules. 42, 43 To examine whether LDL modulated the expression of PLA 2 genes, human monocyte-derived macrophages were incubated with various LDL preparations displaying different degrees of oxidation, and PLA 2 mRNA levels were assessed by RT-PCR. Transcription of the group IV and V PLA 2 s was unaffected by the LDL treatments. However, an interesting finding was that group IIa snpPLA 2 mRNA was strongly induced in macrophages by MM-LDL and mildly oxidized LDL (Figure 3 ). Native LDL (protected from oxidation with EDTA and used immediately after preparation) did not induce snpPLA 2 group IIa expression, whereas native LDL left for 8 days at 4°C augmented its expression, possibly owing to increased oxidation on storage ( Figure 4) . MM-LDL and mildly oxidized LDL stimulated snpPLA 2 expression to a greater extent than did LDL oxidized in the presence of copper ions. This indicates that a slight oxidative modification of LDL particles is necessary to stimulate the expression of group IIa snpPLA 2 .
Treatment of macrophages with acetylated or extensively oxidized LDL did not affect mRNA levels of group IIa PLA 2 , suggesting that the LDL-regulated expression of group IIa PLA 2 s is not mediated by the scavenger receptor A family of scavenger receptors. The results presented herein were obtained by treatment of macrophages with LDL for 6 hours. During this 6-hour incubation period, we did not detect any significant increase in the cholesteryl ester content (as assessed in a classic colorimetric assay; data not shown), thus suggesting that massive cholesterol loading of macrophages was not involved in the induction of group IIa snpPLA 2 mRNA. Additionally, the preparations of native LDL failed to induce snpPLA 2 , suggesting that the classic LDL receptor was not involved, either. However, we may not exclude the implication that CD36, a member of the scavenger receptor B family 44 of scavenger receptors, is involved in the regulation of group IIa snpPLA 2 transcription. Moreover, the possibility also exists that non-receptor-mediated pathways, ie, the heparin sulfate proteoglycan-facilitated 45 uptake of LDL, could be involved in regulating group IIa PLA 2 mRNA synthesis. Uptake of modified LDL by macrophages results in formation of macrophage foam cells and is a key cellular event in the early stage of atherosclerosis. Secretory PLA 2 s have been suggested to generate LDLs of a more atherogenic form. We have previously shown that the human recombinant group IIa PLA 2 is able to hydrolyze LDL in vitro and that the hydrolytic rate is increased 4-fold in the presence of intimal matrix components like chondroitin sulfate chains. 20 It has additionally been found that PLA 2 -treated LDL is taken up more avidly by macrophages 25 and equally, that the PLA 2 -treated LDLs enhance release of macrophage colony stimulating factor from macrophages, thus inducing macrophage growth, which is probably linked to the development of atherosclerotic lesions. 39 Furthermore, mild oxidation of LDL leads to an increased susceptibility of LDL phospholipids to hydrolysis by PLA 2 . 46 Thus, our data showing that mildly oxidized LDL (Ϸ5 to 16 nmol malondialdehyde per milligram LDL protein) regulates the transcription of the group IIa snpPLA 2 gene are in favor of a prominent role for snpPLA 2 in early atherogenesis.
In conclusion, we suggest that the enzymes of the PLA 2 family may possess critical roles in macrophage function during the early stages of atherosclerosis. Group IIa snpPLA 2 expression seems to be a specific response of intimal macrophages to their exposure to MM-LDL and mildly oxidized LDL, hence enabling the cells to modify and scavenge LDL accumulating in the intima. Future studies will elucidate the mechanisms implicated in LDL-induced gene expression of group IIa snpPLA 2 and will allow identification of the lipoprotein receptor(s) involved.
